OPEN MARKET SALE AGREEMENTSMOpen Market Sale • May 9th, 2019 • Ra Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Ra Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Common Shares”), having an aggregate offering price of up to the Maximum Program Amount (as defined herein), on the terms set forth in this agreement (this “Agreement”).
